Acutus Medical, Inc. (AFIB)
Stock analysis · OTC · Healthcare · Medical - Devices
Acutus Medical, Inc. (AFIB) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $2.99K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Acutus Medical, Inc.
Acutus Medical, Inc. is a company dedicated to the treatment of cardiac arrhythmias, focusing on the design, manufacturing, and commercialization of specialized tools for catheter-based ablation procedures. These solutions are utilized to manage a spectrum of heart rhythm disorders across both domestic U.S. and international markets. The firm's extensive product offerings include innovative access sheaths, transseptal crossing devices, diagnostic and mapping catheters, along with both traditional and contact-force ablation catheters. It also provides advanced mapping and imaging consoles, accompanying accessories, and vital supporting algorithms and software. Acutus Medical, Inc. was established in 2011 and is headquartered in Carlsbad, California.
Valuation
| P/E (TTM) | -0.00× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -0.00× |
| P/FCF (TTM) | -0.00× |
| EV / EBITDA | 9.67× |
| EV / Sales | 1.08× |
| Earnings Yield | -320711.28% |
| Free Cash Flow Yield | -1062253.43% |
Fundamentals
| Enterprise Value | $21.75M |
|---|---|
| Revenue (TTM) | $20.16M |
| Net Income (TTM) | -$9.59M |
| Free Cash Flow (TTM) | -$26.01M |
| Net Debt | $21.75M |
| Working Capital | $13.14M |
| Gross Margin | 5.03% |
| Operating Margin | -0.28% |
| Net Margin | -47.36% |
| Return on Equity | 153.11% |
| Return on Invested Capital | -0.24% |
Peers
Recent News
Related
Browse more tickers: sitemap